Mashelkar Foundation



Dr. Shyam Vasudeva Rao

The Problem

The prevalence of Chronic Kidney Disease (CKD) in the global population is a huge 10% share. Diabetes and high Blood Pressure patients are very likely prone to CKD- indicating 1.5 billion population at high risk. CKD is asymptomatic in early stages and rapidly progresses into End Stage Renal Disease (ESRD) if not managed. Many patients with CKD have no idea until they just have 10-15% of kidney function remaining towards the end stage. CKD is notoriously called the ‘silent killer’. ESRD patients need dialysis treatment. Of the 200-300k patients of ESRD every year, only 10-30% can get access to a dialysis machine. All other patients die with ESRD due to lack of access or affordability to a dialysis machine.

The Inclusive Innovation

Renalyx is an end-to-end CKD care solution, uniquely equipped with products for the complete cycle of CKD. Renalyx involves products and solutions across three aspects of ‘Reach’, ‘Care’ and ‘Treat’. The ‘Reach’ aspect involves point-of-care, early detection CKD kits which perform patented colorimetric testing. These kits are linked to an android application on the mobile phone and offer immediate results. The kits are priced at least 50% lower than similar other Indian and foreign solutions. The ‘Care’ aspect covers workflow based clinical management of CKD patients to doctors. All details including personal health records, statistics, nutrition programs, doctors’ appointments are tracked for every patient. With the principle of what’s tracked can be monitored and improved, the disease management workflow offers a great solution to manage CKD for both doctors and patients. The ‘Treat’ aspect covers smart connected dialysis machines. The machine offers remote tracking for doctors, offers personalized dialysis prescription with AI-driven analytics, offers an intuitive interface to the users and automates some of the manual steps. More importantly, the machine costs 30-40% of a typical machine and can bring down the cost of dialysis also by 70-80%. Renalyx products also involve a portable home hemodialysis machines with an easy setup. Renalyx thus offers a holistic end-to-end care for CKD to ESRD patients with a host of hardware-cum-software solutions and at affordable prices!

The Impact

The Renalyx dialysis machine has received the ISO and CE certifications. It is in partnerships with multiple government stakeholders like Technology Development Board, IIT Kharagpur, BIRAC, Andhra Pradesh MedTech Zone (AMTZ) and Navratna Defence PSU Bharat Electronics Limited (BEL). Renalyx signed an agreement with BHEL in 2021. Through this MoU, Renalyx would be providing the necessary Transfer of Technology and License Grant to BEL on an exclusive basis for manufacture and sale of its Haemodialysis machine. Renalyx has also partnered with multiple private partners like GenWorks, Bangalore Kidney Foundation, Rangadore Memorial Hospital, Aquaporin, Browndove, IcarusNova, Bhat Biotech and few others.

Know More

Watch The Award Ceremony


Dr. Shyam Vasudeva Rao

Manmohan Jain

Manmohan is the COO of Salcit Technologies. Manmohan has over 20 years of experience in diverse technical and managerial roles, including software design, product development, technical management, and operations.